Background: A wide range of diseases or reactions can cause pustular erupti
ons of the skin. In this spectrum there seems to be a subgroup with charact
eristic clinical features and a typical course which is mostly caused by dr
ugs for which the term acute generalized exanthematous pustulosis (AGEP) ha
s been established.
Objective: To describe the clinical features of AGEP.
Methods: The authors' experience from a multinational epidemiological study
on severe cutaneous adverse reactions and a comprehensive review of the li
terature were used to provide an overview of the disease and it's possible
causes. An algorithm for validating cases which was established for this st
udy is also presented.
Results: AGEP typically presents with at least dozens of non follicular ste
rile pustules occurring on a diffuse, edematous erythema pre dominalty in t
he folds and/or on the face. Fever and elevated blood neutrophils are commo
n. Histopathology typically shows spongiform subcorneal and/or intraepiderm
al pustules, a marked edema of the papillary dermis, and eventually vasculi
tis, eosinophils and/or focal necrosis of keratinocytes. Onset is acute, mo
st often following drug intake, but viral infections can also trigger the d
isease. Pustules resolve spontaneously in less than 15 days.
Conclusion: The diagnosis AGEP should be considered in cases of acute pustu
lar rashes and detection of the causative drug should be strived for. Knowl
edge of the clinical features and usual course of this disease can often pr
event unnecessary therapeutical measures.